UPDATE: CME, Newedge Battle For OTC Clearing Business
March 13 2012 - 5:29PM
Dow Jones News
Competition intensified on Tuesday for potentially lucrative
clearing of over-the-counter interest-rate derivatives as CME Group
Inc. (CME) announced plans to cut clients' costs on trades they
perform away from exchanges, while Newedge Group became the first
major brokerage to enter the fray.
Exchanges and brokerage firms hope to capitalize on new
regulations on both sides of the Atlantic that are pushing traders
to clear more business previously done on a bilateral basis.
Newedge said it will become the first independent futures
commission merchant to guarantee interest-rate swaps, in a joint
venture with shareholders Societe Generale SA (GLE.FR) and Credit
Agricole SA (ACA.FR) that is expected to start in the second
quarter.
Beginning May 7, CME will offer to its member firms
portfolio-margining of over-the-counter interest-rate swaps,
Treasury, and Eurodollar futures. Margins or collateral required to
guarantee trades will be charged based on a market participant's
entire portfolio, rather than for an individual product. CME
estimated that certain portfolios will produce savings of up to
85%.
"The exact amount of dollar relief depends on how your portfolio
is constructed," Laurent Paulhac, head of OTC products and services
at CME, said in an interview Tuesday.
Paulhac added that portfolio margining in other asset classes
beyond interest-rate swaps is a goal downstream. He said that rates
have "been our big focus, but as we expand into other asset
classes, like FX, where there is a strong correlation we will be
able to offer the same," he said.
Initially, CME will provide portfolio margining only to its
member firms, meaning dealer banks. Regulatory approval is needed
before the derivatives exchange offers the benefit to its broader
customer base, which is where the vast majority of CME's business
comes from in clearing. Its customers include hedge funds,
insurance companies, regional banks and government-sponsored
enterprises.
Paulhac said CME has been in discussions with regulators and
hopes to get approval in 2012 to launch portfolio margining for
customers in rate swaps sometime in 2012. It has offered portfolio
margining in futures for several years.
-By Howard Packowitz and Katy Burne, Dow Jones Newswires;
312-750-4132; howard.packowitz@dowjones.com
CME (NASDAQ:CME)
Historical Stock Chart
From May 2024 to Jun 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Jun 2023 to Jun 2024